Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Glob Antimicrob Resist ; 37: 165-167, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38458537

RESUMO

PURPOSE: The impact of the COVID-19 pandemic on antimicrobial resistance (AMR) is largely studied in healthcare settings. There is a need to understand the fluctuations in AMR during pandemic at the community level. With urinary tract infection (UTI) being one of the most common infections in the community, the AMR profile of community-acquired UTI (CA-UTI) is considered representative AMR at the community level. METHODS: The study was taken in a cohort of patients with a clinical diagnosis of CA-UTI. The four study sites represented different community health centres in India. Escherichia coli isolates were analysed phenotypically and genotypically for AMR pre-COVID (October 2019-February 2020) and in the first (March 2020-February 2021) and second waves of COVID-19 (March 2021-December 2021). RESULTS: E. coli was the predominant uropathogen (229, 82%). Increased susceptibility to nitrofurantoin was observed during the pandemic. Reduced susceptibility to first-line oral antibiotics and carbapenems was seen during the second wave, and an increased minimum inhibitory concentration (MIC50) to beta-lactams and fluoroquinolones was seen during the pandemic. Genomic analysis of E. coli isolates showed some AMR genes (aacC1, aacC4, SHV, QepA) only during the second wave. CONCLUSION: One good outcome of the pandemic was increased susceptibility to nitrofurantoin, while drawback was a significant decrease in susceptibility to oral antibiotics during the second wave and increased MIC50 of some antibiotics. Decreased susceptibility to last-resort carbapenems and the occurrence of various AMR genes during the second wave of the pandemic are of great concern.


Assuntos
Antibacterianos , COVID-19 , Infecções Comunitárias Adquiridas , Infecções por Escherichia coli , Escherichia coli , Testes de Sensibilidade Microbiana , Infecções Urinárias , Humanos , Infecções Urinárias/microbiologia , Infecções Urinárias/epidemiologia , Índia/epidemiologia , COVID-19/epidemiologia , COVID-19/microbiologia , Infecções Comunitárias Adquiridas/microbiologia , Infecções Comunitárias Adquiridas/epidemiologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/microbiologia , Infecções por Escherichia coli/epidemiologia , Antibacterianos/farmacologia , SARS-CoV-2/efeitos dos fármacos , SARS-CoV-2/genética , Farmacorresistência Bacteriana , Pandemias , Feminino
2.
J Membr Biol ; 255(2-3): 185-209, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-35333977

RESUMO

Biological membrane remodeling is central to living systems. In spite of serving as "containers" of whole-living systems and functioning as dynamic compartments within living systems, biological membranes still find a "blue collar" treatment compared to the "white collar" nucleic acids and proteins in biology. This may be attributable to the fact that scientific literature on biological membrane remodeling is only 50 years old compared to ~ 150 years of literature on proteins and a little less than 100 years on nucleic acids. However, recently, evidence for symbiotic origins of eukaryotic cells from data only on biological membranes was reported. This, coupled with appreciation of reproducible amphiphilic self-assemblies in aqueous environments (mimicking replication), has already initiated discussions on origins of life beyond nucleic acids and proteins. This work presents a comprehensive compilation and meta-analyses of data on self-assembly and vesicular transformations in biological membranes-starting from model membranes to establishment of Influenza Hemagglutinin-mediated membrane fusion as a prototypical remodeling system to a thorough comparison between enveloped mammalian viruses and cellular vesicles. We show that viral membrane fusion proteins, in addition to obeying "stoichiometry-driven protein folding", have tighter compositional constraints on their amino acid occurrences than general-structured proteins, regardless of type/class. From the perspective of vesicular assemblies and biological membrane remodeling (with and without proteins) we find that cellular vesicles are quite different from viruses. Finally, we propose that in addition to pre-existing thermodynamic frameworks, kinetic considerations in de novo formation of metastable membrane structures with available "third-party" constituents (including proteins) were not only crucial for origins of life but also continue to offer morphological replication and/or functional mechanisms in modern life forms, independent of the central dogma.


Assuntos
Fusão de Membrana , Ácidos Nucleicos , Animais , Membrana Celular/metabolismo , Mamíferos , Membranas , Ácidos Nucleicos/análise , Ácidos Nucleicos/metabolismo , Proteínas Virais de Fusão/metabolismo , Internalização do Vírus
3.
Curr Drug Targets ; 15(8): 753-61, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24975562

RESUMO

To screen the active antimalarial novel artemisinin derivatives, a QSAR modeling approach was used. QSAR model showed high correlation (r(2)= 0.83 and rCV(2)= 0.81) and indicated that Connectivity Index (order 1, standard), Connectivity Index (order 2, standard), Dipole Moment (debye), Dipole Vector X (debye) and LUMO Energy (eV) well correlate with activity. High binding likeness on antimalarial target plasmepsin was detected through molecular docking. Active artemisinin derivatives showed significant activity and indicated compliance with standard parameters of oral bioavailability and ADMET. The active artemisinin derivatives namely, ß-Artecyclopropylmether HMCP (A3), ß- Artepipernoylether (PIP-1) (A4) and 9-(ß-Dihydroartemisinoxy)methyl anthracene (A5) were semi-synthesized and characterized based on its (1)H and (13)C NMR spectroscopic data and later activity tested in vivo on mice infected with multidrug resistant strain of P. yoelii nigeriensis. Predicted results were successfully validated by in vivo experiments.


Assuntos
Antimaláricos/metabolismo , Antimaláricos/farmacocinética , Artemisininas/metabolismo , Artemisininas/farmacocinética , Ácido Aspártico Endopeptidases/química , Malária/tratamento farmacológico , Proteínas de Protozoários/química , Animais , Artemisininas/química , Ácido Aspártico Endopeptidases/metabolismo , Sítios de Ligação , Disponibilidade Biológica , Desenho Assistido por Computador , Modelos Animais de Doenças , Desenho de Fármacos , Espectroscopia de Ressonância Magnética , Malária/parasitologia , Camundongos , Simulação de Acoplamento Molecular , Plasmodium yoelii/efeitos dos fármacos , Proteínas de Protozoários/metabolismo , Relação Quantitativa Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA